🇺🇸 FDA
Patent

US 8304428

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

granted A61PA61P35/00

Quick answer

US patent 8304428 (Compounds and methods for inhibiting the interaction of BCL proteins with binding partners) held by Infinity Discovery, Inc. expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infinity Discovery, Inc.
Grant date
Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61P, A61P35/00